225 related articles for article (PubMed ID: 17853310)
21. Decision points for the initiation of systemic treatment for psoriasis.
Feldman SR; Koo JY; Menter A; Bagel J
J Am Acad Dermatol; 2005 Jul; 53(1):101-7. PubMed ID: 15965429
[TBL] [Abstract][Full Text] [Related]
22. The management of psoriasis in children and adolescents.
Pootrakul L; Kalb RE
G Ital Dermatol Venereol; 2010 Apr; 145(2):259-68. PubMed ID: 20467399
[TBL] [Abstract][Full Text] [Related]
23. Biological therapies in the systemic management of psoriasis: International Consensus Conference.
Sterry W; Barker J; Boehncke WH; Bos JD; Chimenti S; Christophers E; De La Brassinne M; Ferrandiz C; Griffiths C; Katsambas A; Kragballe K; Lynde C; Menter A; Ortonne JP; Papp K; Prinz J; Rzany B; Ronnevig J; Saurat JH; Stahle M; Stengel FM; Van De Kerkhof P; Voorhees J
Br J Dermatol; 2004 Aug; 151 Suppl 69():3-17. PubMed ID: 15265063
[TBL] [Abstract][Full Text] [Related]
24. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
25. Phototherapy for Psoriasis in the Age of Biologics.
Sandoval AGW; Mahajan A; Buzney E
Dermatol Clin; 2024 Jul; 42(3):399-404. PubMed ID: 38796271
[TBL] [Abstract][Full Text] [Related]
26. Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease.
Cameron H; Yule S; Dawe RS; Ibbotson SH; Moseley H; Ferguson J
Public Health; 2014 Apr; 128(4):317-24. PubMed ID: 24726005
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
[TBL] [Abstract][Full Text] [Related]
28. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
Stein KR; Pearce DJ; Feldman SR
Semin Cutan Med Surg; 2005 Mar; 24(1):52-7. PubMed ID: 15900799
[TBL] [Abstract][Full Text] [Related]
29. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
Christophers E; Segaert S; Milligan G; Molta CT; Boggs R
J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684
[TBL] [Abstract][Full Text] [Related]
30. Phototherapy and photochemotherapy.
Schneider LA; Hinrichs R; Scharffetter-Kochanek K
Clin Dermatol; 2008; 26(5):464-76. PubMed ID: 18755365
[TBL] [Abstract][Full Text] [Related]
31. The cost of psoriasis.
Crown WH
Manag Care; 2003 May; 12(5 Suppl):10-3; discussion 20-1. PubMed ID: 18564553
[TBL] [Abstract][Full Text] [Related]
32. PsoReg--the Swedish registry for systemic psoriasis treatment. The registry's design and objectives.
Schmitt-Egenolf M
Dermatology; 2007; 214(2):112-7. PubMed ID: 17341858
[TBL] [Abstract][Full Text] [Related]
33. Inpatient management of severe psoriasis.
Nelson AA; Pearce DJ; Fleischer AB; Balkrishnan R; Feldman SR
J Drugs Dermatol; 2005; 4(5):564-70. PubMed ID: 16167414
[TBL] [Abstract][Full Text] [Related]
34. Tanning beds as an alternative for psoriasis when office-based phototherapy is not accessible.
Yentzer BA; Feldman SR
J Dermatolog Treat; 2009; 20(4):238-40. PubMed ID: 19065355
[TBL] [Abstract][Full Text] [Related]
35. Overview of psoriasis: update on current and emerging treatment options.
Leonardi CL
Manag Care; 2003 May; 12(5 Suppl):3-9; discussion 20-1. PubMed ID: 18567143
[TBL] [Abstract][Full Text] [Related]
36. Cost comparison of psoriasis treatments.
Mikhael D; Babcock K; DesGroseilliers JP
J Cutan Med Surg; 2009; 13(6):303-7. PubMed ID: 19919807
[TBL] [Abstract][Full Text] [Related]
37. Economic considerations in psoriasis management.
Radtke MA; Augustin M
Clin Dermatol; 2008; 26(5):424-31. PubMed ID: 18755360
[TBL] [Abstract][Full Text] [Related]
38. Phototherapy coding and documentation in the time of biologics.
Rogers HW
Cutis; 2017 Jul; 100(1):41-42. PubMed ID: 28873108
[No Abstract] [Full Text] [Related]
39. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines.
Nast A; Erdmann R; Hofelich V; Reytan N; Orawa H; Sterry W; Rzany B
Arch Dermatol Res; 2009 Sep; 301(8):553-9. PubMed ID: 19609542
[TBL] [Abstract][Full Text] [Related]
40. Home ultraviolet light therapy for psoriasis: why patients choose other options.
Dothard EH; Sandoval LF; Yentzer BA; Feldman SR
Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
